✦ LIBER ✦

Pilot study of etoposide and split-dose CDDP and THP with rhG-CSF for unresectable non small cell lung cancer (NSCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of etoposide and splitt

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 91 KB

348 Concurrent full-dose cisplatin and e

✍ Millward, M.J.; Tebbutt, N.; Wirth, A.; Ryan, G.; Ball, D.L. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Intensive chemotherapy with carboplatin,

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Treatment of unresectable non-small cell

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 148 KB

A phase I study of dose-dense “alternati

✍ Watson, S.M; Gordon, G.S; Mauer, A.M; Rudin, C.R; Hoffman, P.C; Krauss, S.A; Sze 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

High remission rates in the treatment of

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 92 KB